Video
Career Development at Catalent
Summary: Catalent offers employees numerous opportunities for development and career progression. Hear more about what our team has to say about how Catalent supports their...
View Now
Video
Product Development Careers at Catalent
Summary: Members of our product development gain unparalleled experience working on several products using multiple technologies. Hear what it's like to work...
View Now
Offering Fact Sheet
Zydis® ODT Consistently Offers Effective Solutions for Sublingual Allergy Immunotherapy
Summary: ALK-Abelló A/S is a Denmark-based pharmaceutical company that specializes in the development of immunotherapy products for the treatment of respiratory allergies. ALK partnered with Catalent for...
View Now
Webinars
Beyond HPLCs: Advanced Analytical Tools for the Development and Analysis of Drug Products
Summary: Advanced analytical techniques can provide timely insights into a product’s stability, performance, and composition. Download this webinar to get expert insights on the applications of analytical techniques to help answer various questions...
View Now
Webinars
An Integrated Approach to Spray Drying - From Scale-up to Manufacturing
Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. Nearly 40% of the new chemical entities (NCEs) screened by pharmaceutical...
View Now
Webinars
Unlock Industry Perspectives on the Advantages and Challenges of Developing Advanced Dosage Forms
Summary: Watch the webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.
View Now
Webinars
Strategies To Develop Lipid-Based Drug Delivery Systems And Oral Dosage Forms
Summary: Liquid-filled capsules (LFC) are the primary delivery platform for oral delivery of lipid formulations which includes both softgels and liquid-filled hard capsules. Liquid-in-bottle is...
View Now
Article
Overcoming Manufacturing Challenges For Accelerated Drug Development
Summary: It has been reported that surveys of migraine patients have revealed a preference for oral medications with a rapid onset of action that leads to a resolution of their symptoms. Due to the random nature of migraine attacks..
View Now
Case Study
Zydis® ODT Unlocks a Patient Preference for Rapid Onset in the Treatment of Migraine
Summary: It has been reported that surveys of migraine patients have revealed a preference for oral medications with a rapid onset of action that leads to a resolution of their symptoms. Due to the random nature of migraine attacks..
View Now
eBook
Why Do New Therapies Succeed Or Fail In The Marketplace?
How can decisions made during the preclinical phase of drug development increase the chances of a product’s eventual success in a difficult marketplace?
View Now
